N-Boc Fluvoxamine | CAS 192876-04-3 - Request Quote
N-Boc Fluvoxamine
| SZ CAT No: | SZ-F007035 |
| CAS No | 192876-04-3 |
| Mol.F. | C20H29F3N2O4 |
| Mol.Wt. | 418.5 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N-Boc Fluvoxamine is chemically Tert-butyl (Z)-(2-(((5-methoxy-1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)carbamate. N-Boc Fluvoxamine is supplied with detailed characterization data compliant with regulatory guideline. N-Boc Fluvoxamine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluvoxamine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 192876-04-3
Purchase 192876-04-3
Order 192876-04-3
Enquire 192876-04-3
price of 192876-04-3
192876-04-3 Supplier
192876-04-3 Manufacturer
192876-04-3 Exporter
buy high quality N-Boc Fluvoxamine
Purchase N-Boc Fluvoxamine
N-Boc Fluvoxamine suppliers
N-Boc Fluvoxamine manufacturers
N-Boc Fluvoxamine price
Order N-Boc Fluvoxamine
Enquire N-Boc Fluvoxamine
N-Boc Fluvoxamine cost
N-Boc Fluvoxamine Supplier
N-Boc Fluvoxamine Distributor
N-Boc Fluvoxamine for Method Validation
Fluvoxamine Reference Standard
N-Boc Fluvoxamine for ANDA Filing
N-Boc Fluvoxamine for Forced Degradation Studies
N-Boc Fluvoxamine Identification Standards
N-Boc Fluvoxamine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


